Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|May 7, 2026
The GA4GH Categorical Variation Representation Specification: A Unified Computational Framework for Reasoning over Genomic Variant CategoriesDaniel Puthawala, Brendan Reardon, Lawrence Babb, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapyYingxiao Shi, Zoltan Maliga, Tuulia Vallius, et al.
JCO Precision Oncology|July 21, 2018
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid TumorsKelly Klega, Alma Imamovic-Tuco, Gavin Ha, et al.
Cancer Cell|February 11, 2025
Genomic mediators of acquired resistance to immunotherapy in metastatic melanomaJulia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 28, 2013
A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health recordPeter Tarczy-Hornoch, Laura Amendola, Samuel J Aronson, et al.
Investigational New Drugs|July 1, 2015
Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancerSara M Tolaney, Sally Tan, Hao Guo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Implementing a context-augmented large language model to guide precision cancer medicineHyeji Jun, Yutaro Tanaka, Shreya Johri, et al.
JCO Precision Oncology|February 19, 2021
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never SmokedAmin H Nassar, Kevin Lundgren, Mark Pomerantz, et al.
JCO Precision Oncology|September 14, 2020
Engaging Patients in Precision Oncology: Development and Usability of a Web-Based Patient-Facing Genomic Sequencing ReportIlana B Solomon, Sarah McGraw, Jenny Shen, et al.
NPJ Breast Cancer|August 26, 2021
Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker studyRomualdo Barroso-Sousa, Tanya E Keenan, Tianyu Li, et al.
Pageof 6